Viewing Study NCT02680951


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-03 @ 6:36 PM
Study NCT ID: NCT02680951
Status: WITHDRAWN
Last Update Posted: 2018-04-19
First Post: 2016-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module